LifePoint Health, Inc. (NASDAQ:LPNT) – Analysts at Cantor Fitzgerald reduced their FY2017 EPS estimates for LifePoint Health in a note issued to investors on Wednesday. Cantor Fitzgerald analyst J. France now anticipates that the company will post earnings of $3.75 per share for the year, down from their previous estimate of $4.15. Cantor Fitzgerald also issued estimates for LifePoint Health’s FY2018 earnings at $4.20 EPS.

Several other equities analysts have also weighed in on LPNT. Robert W. Baird set a $55.00 target price on shares of LifePoint Health and gave the company a “buy” rating in a report on Monday. BMO Capital Markets decreased their target price on shares of LifePoint Health from $59.00 to $55.00 and set a “market perform” rating on the stock in a report on Monday. SunTrust Banks, Inc. set a $54.00 target price on shares of LifePoint Health and gave the company a “hold” rating in a report on Tuesday. Leerink Swann reiterated an “outperform” rating and issued a $58.00 target price (down from $74.00) on shares of LifePoint Health in a report on Tuesday. They noted that the move was a valuation call. Finally, Mizuho set a $50.00 price objective on shares of LifePoint Health and gave the stock a “hold” rating in a report on Friday, October 27th. Three investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $60.57.

TRADEMARK VIOLATION WARNING: This article was first reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/11/02/fy2017-eps-estimates-for-lifepoint-health-inc-lpnt-cut-by-analyst.html.

LifePoint Health (NASDAQ:LPNT) last issued its earnings results on Friday, October 27th. The company reported $0.80 EPS for the quarter, missing the Zacks’ consensus estimate of $0.95 by ($0.15). The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.60 billion. LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The business’s revenue was down .7% compared to the same quarter last year. During the same period last year, the business posted $0.94 earnings per share.

Several hedge funds have recently modified their holdings of LPNT. Legal & General Group Plc lifted its holdings in shares of LifePoint Health by 30.4% in the 1st quarter. Legal & General Group Plc now owns 57,028 shares of the company’s stock worth $3,736,000 after acquiring an additional 13,304 shares during the last quarter. Thrivent Financial For Lutherans lifted its holdings in shares of LifePoint Health by 9.2% in the 1st quarter. Thrivent Financial For Lutherans now owns 7,570 shares of the company’s stock worth $496,000 after acquiring an additional 640 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of LifePoint Health by 3.8% in the 1st quarter. Vanguard Group Inc. now owns 3,266,963 shares of the company’s stock worth $213,986,000 after acquiring an additional 120,201 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of LifePoint Health by 4.9% in the 1st quarter. Geode Capital Management LLC now owns 330,096 shares of the company’s stock worth $21,620,000 after acquiring an additional 15,276 shares during the last quarter. Finally, Morgan Stanley lifted its holdings in shares of LifePoint Health by 26.2% in the 1st quarter. Morgan Stanley now owns 98,008 shares of the company’s stock worth $6,421,000 after acquiring an additional 20,338 shares during the last quarter. Hedge funds and other institutional investors own 99.53% of the company’s stock.

LifePoint Health announced that its Board of Directors has authorized a stock repurchase program on Friday, October 27th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its shares are undervalued.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.